Dr. Elina Jerschow is a Professor of Medicine (Allergy and Immunology) and an attending physician for pediatric and adult allergy and immunology at Einstein/Montefiore. 

After completing her fellowship, Dr. Jerschow joined Merck & Co., Inc. as an associate director in the Department of Clinical Immunology. During the work at Merck, her main research focused on the evaluation of adverse drug reactions in study participants and on developing new therapeutic targets in the area of immunology.

After returning to the Einstein/Montefiore Department of Medicine, Dr. Jerschow established a Center for AERD and Drug Allergy. She is providing continuous care to patients with AERD and allergies to medications. She has also been selected as New York Times Super Doctor and NY Top Doctor for several years.

Dr. Jerschow’s current research goals include the following:

• "Dr. Jerschow’s current research goals are directed at the understanding of the role of nasal polyps and the impact of the immune cell subsets in polyp tissue on AERD severity.

Media Coverage

Diagnosis: A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed New York Times, Dec. 12, 2019

Nasal Polypectomy Is Associated With Reduction In Aspirin Sensitivity In AERD 2019

Delabeling Penicillin Allergies Through Oral Challenges 2019 

Explaining Your Running Habit on Vacation. Comments on running during allergy season New York Times, 2018 

Asthma Risk Varies Among Hispanic Groups After Relocation to the US 2017

Poor Asthma Sufferers Often Stuck in Homes That Worsen Their Disease 2017

Treatment of Aspirin Exacerbated Respiratory Disease in Minorities 2017

Fatal anaphylaxis in the U.S. 2014

Editor’s pick for featuring in The Editor’s Choice of the J Allergy Clin Immunology. Also featured in the New Research section of the American Academy of Allergy, Asthma and Immunology website

Also cited by major media companies, including The New York Times, US News, Medscape, etc.

• New York Times
• US News
• HealthDay
• http://www.medscape.com/viewarticle/832749

Dichlorophenols and allergies 2012

Editor’s pick for press release

Also cited by major media companies, including CNN, Time, Telegraph, Discovery, Voice of America

• Time
• CNN.com
• Telegraph
• CBS News
• VOA News
• Fox News
• ABC News

Selected publications:

1. Jerschow E., Edin M.L., Chi Y., Hurst B., Abuzeid W.M., Akbar N.A., Gibber M., Fried M., Han W., Pelletier T., Z. Ren, Keskin T., Roizen Gottlieb G., Lih F.B., Gruzdev A., Bradbury J.A., Schuster V., Spivack S., RosenstreichD, Zeldin D.C. Sinus surgery is associated with a decrease in aspirin-induced reaction severity in AERD patients. J Allergy Clin Immunol: In Practice, 2019. PMID: 30580047 Editor’s pick for featuring in the New Research section of the AAAAI website and for Practice Matters section of JACI in Practice. This study was also featured in an Editorial.
2. Pelletier T., Roizen G., Ren Z., Hudes G., Rosenstreich D., Jerschow E. Comparable safety of two aspirin desensitization protocols for aspirin-exacerbated respiratory disease (AERD). The Journal of Allergy and Clinical Immunology: In Practice, 2018, PMID: 30144584
3. Feldman JM, Zeigler AE, Nelson K, Morales E, Pelletier T, Roizen Gottlieb G, Ren Z., Jerschow E. Depression symptoms and quality of life among individuals with Aspirin-Exacerbated Respiratory Disease. J Asthma, 2018, PMID: 29972652
4. Iammatteo M., Alvarez-Arango, S., Ferastraoaru D., Akbar N., Lee A.Y., Cohen H.W., Jerschow E. Safety and Outcomes of Oral Graded Challenges to Amoxicillin without Prior Skin Testing. The Journal of Allergy and Clinical Immunology: In Practice, 2018. PMID: 29802906. Editor’s pick for featuring in the New Research section of the American Academy of Allergy, Asthma and Immunology website
5. Jerschow E., Edin M.L., Pelletier T., Abuzeid W.M., Akbar N.A., Gibber M., Fried M., Lih F.B., Gruzdev A., Bradbury J.A., Han W., Hudes G., Keskin T., Schuster V., Spivack S., Zeldin D.C., RosenstreichD. Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol: In Practice. 2017 PMID: 28159558
6. Scaperotti M., Gil N., Downs I., Jeyakuma A., Liu A., MD, Chan J., Bonner J., Kelly M.S., Nosanchuk J.D., Cohen H.W., Jerschow E. Development and evaluation of a web-based dermatology teaching tool for preclinical medical students. MedEdPortal for Association of American Medical Colleges (AAMC) 2017 https://www.mededportal.org/publication/10619/ The Editor’s Choice for Exemplary Educational Resource
7. Jerschow E., Lin R.Y., Scaperotti M., McGinn A.P. Fatal anaphylaxis in the United States 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol 2014, 134(6):1318-1328. PMID: 25280385. Editor’s pick for featuring in The Editor’s Choice of the J Allergy Clin Immunology and in the New Research section of the American Academy of Allergy, Asthma and Immunology website